Identification of an epitope derived from human proteolipid protei nthat can induce autoreactive CD8+ cytotoxic T lymphocytes restricted by HLA-A3: Evidence for cross-reactivity with an environmental microorganism

Journal of Neuroimmunology

Volumn 73, Issue 1-2, 1997, Pages 7-14

  Honma, Kiri ^a   Parker, Kenneth C ^b   Becker, Kevin G ^a   McFarland, Henry F ^a   Coligan, John E ^b   Biddison, William E ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

autoimmunity; cytotoxic T cells; HLA; molecular mimicry; multiple sclerosis

Indexed keywords

CD8 ANTIGEN; CYTOKINE; HLA A3 ANTIGEN; PROTEOLIPID PROTEIN; SYNTHETIC PEPTIDE;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

ADULT; APOPROTEINS; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CROSS REACTIONS; CYTOKINES; EPITOPES; FEMALE; FUNGAL PROTEINS; HLA-A3 ANTIGEN; HUMANS; KARYOPHERINS; MALE; MYELIN PROTEOLIPID PROTEIN; PEPTIDE FRAGMENTS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SACCHAROMYCES CEREVISIAE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031048921     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00161-0     Document Type: Article

References (35)

1. Barnett, L., Whitton, J., Wada, Y. and Fujinami, R. (1993) Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J. Neuroimmunol. 44, 15-25.
2. Bennink, J. and Yewdell, J. (1988) Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of non-responder MHC class I alleles. J. Exp. Med. 168, 1935-1939.
3. Berger, A., Davis, J., and Cresswell, P. (1982) Monoclonal antibody to HLA-A3. Hybridoma 1, 87-90.
4. Beutler, B. and Cerami. A. (1989) The biology of cachectin/TNF - a primary mediator of the host response. Annu. Rev. Immunol. 7, 625-655.
5. Booss, J., Esiri, M., Tourtellotte, W. and Mason, D. (1983) Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62, 219-232.
6. Chin, Y., Cai, J. and Johnson, K. (1990) Lymphocyte adhesion to cultured Peyer's patch high endothelial venule cells is mediated by organ-specific homing receptors and can be regulated by cytokines. J. Immunol. 145, 3669-3677.
7. DiBrino, M., Parker, K., Shiloach, J., Knierman, M., Lukszo, J., Turner, R., Biddison, W. and Coligan, J. (1993a). Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc. Natl. Acad. Sci. USA 90, 1508-1512.
8. DiBrino, M., Tsuchida, T., Turner, R., Parker, K., Coligan, J. and Biddison, W. (1993b) HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J. Immunol. 151, 5930-5935.
9. Diehl, H., Schaich, R., Budzinski, R. and Stoffel, W. (1986) Individual exons encode the integral membrane domains of human myelin proteolipid protein. Proc. Natl. Acad. Sci. USA 83, 9807-9811.
10. Fujinami, R. and Oldstone, M.B.A. (1985) Amino acid homology between the encephalitogenic site of myelin basic protein and virus: A mechanism for autoimmunity. Science 230, 1043-1045.
11. Grenier, Y., Ruijs, T., Robitaille, Y., Olivier, A. and Antel, J. (1989) Immunohistochemical studies of adult human glial cells. J. Neuroimmunol. 21, 103-115.
12. Guidotti, L., Ishikawa, T., Hobbs, M., Matzke, B., Schreiber, R. and Chisari, F. (1996) Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4, 25-36.
13. Ho, H., Tiwari, J., Haile, R., Terasaki, P. and Morton, N. (1982) HLA-linked and unlinked determinants of multiple sclerosis. Immunogenetics 15, 509-517.
14. Hofman, F., Hinton, D., Johnson, K., and Merrill, J. (1989) Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170, 607-612.
15. + T cells in murine experimental allergic encephalomyelitis. Science 256, 1213-1215.
16. Koh, D.-R., Fung-Leung, W.-P., Ho, A., Grey, D., Acha-Orbea, H. and T.-W. Mak. (1992) Less mortality but more relapses in experimental allergic encephalomyelitis in CD8 -/- mice. Science 256, 1210-1213.
17. Lees, M. and Bizzozero, O. (1992) Structure and acylation of proteolipid protein. In: R. Martenson, (Ed.), Myelin: Biology and chemistry. CRC Press, Boca Raton, FL, pp. 237-256.
18. Martin, R., McFarland, H. and McFarlin, D. (1992) Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10, 153-187.
19. McFarland, H. and McFarlin, D. (1994) Immunologically mediated demyelinating diseases of the central and peripheral nervous system. In: M. Samter, M. Frank, K. Austen, H. Claman and E. Unanue (Eds.), lmmunologic Diseases, Little, Brown and Co., Boston, pp. 1081-1101.
20. Parker, K., Bednarek, M. and Coligan, J. (1994) Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152, 163-175.
21. + T cells from multiple sclerosis patients. J. Neuroimmunol. 46, 33-42.
22. Selmaj, K., Raine, C, Farooq, M, Norton, W. and Brosnan, C. (1991) Cytokine cytotoxicity against oligodendrocytes. J. Immunol. 147, 1522-1529.
23. Sethna, M. and Lampson, L. (1991) Immune modulation within the brain: Recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma. J. Neuroimmunol. 34, 121-132.
24. Sharief, M. and Hentges, R. (1992) Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 326, 272-273.
25. Sharief, M. and Thompson, E. (1992) In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis. J. Neuroimmunol. 38, 7-33.
26. Storkus, W., Howell, D., Salter, R., Dawson, J. and Cresswell. P. (1987) NK susceptibility varies inversely with target cell class I HLA expression. J. Immunol. 138, 1657-1659.
27. Storkus, W., Jeh, H., Salter, R. and Lotze, M. (1993) Identification of T cell epitopes: rapid elution of class I-presented peptides from viable cells using mild acid elution. J. Immunother. 14, 94-103.
28. Tabira, T. (1988). Autoimmune demyelination in the cental nervous system. Ann. NY Acad. Sci. 540, 187-201.
29. Traugott, U., Reinherz, E. and Raine, C. (1983) Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 219, 308-310.
30. + T cell responses to human myelin protein derived peptides. Proc. Natl. Acad. Sci. USA 91, 10859-10863.
31. Whitham, R., Jones, R., Hashim, G., Hoy, C., Wang, R., Vandenbark, A. and Offner, H. (1991) Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental allergic encephalomyelitis. J. Immunol. 147, 3803-3808.
32. Winter, C., Carreno, B., Turner, R., Koenig, S. and Biddison, W. (1991) The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens J. Immunol. 146, 3508-3512.
33. Wucherpfennig, K. and Strominger, J. (1995) Molecular mimicry in T cell mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 80, 695-705.
34. Yewdell, J. and Bennink, J. (1992) Cell biology of antigen processing and presentation to MHC class I molecule-restricted T lymphocytes. Adv. Immunol. 52, 1-123.
35. Zhang, J., Markovic-Plese, S., Lacet, B., Raus, J., Weiner, H. and Hafler, D. (1994) Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179, 973-984.